The emerging clinical relevance of cell-free DNA in lupus: from mechanistic insights to therapeutic opportunities

• by Emily Jones, Kiki Cano-Gamez

• June 23, 2026

Systemic lupus erythematosus–driven accelerated atherosclerosis: the immune–metabolic–vascular axis and therapeutic implications

• by Meiwei Jiang, FengQi Zhang, MinZhe Ren, ZhiYu Li, ZhiJun Xie, Jing Sun

• June 10, 2026

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

• by Kathryn Wighton

• June 11, 2026

• 2 min

Expression characteristics of C-reactive protein in autoimmune diseases and their complications

• by Qianyue Yang, Yanfang Luo, Yong Luo, Liuting Zeng, Lingyun Sun

• May 11, 2026